Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |